UNH Stock Recent News
UNH LATEST HEADLINES
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices.
NEW YORK, NY / ACCESS Newswire / March 4, 2025 / Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE:UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices. If you currently own shares of UnitedHealth stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=25195for more information.
Verizon is the only Dow Dog meeting the ideal of dividends from $1K invested exceeding its single share price, making it a 'safer' buy. Analysts project net gains of 13.06% to 37.60% from the top ten Dow Dogs by March 2026, with average gains estimated at 23.59%. Six more 'safer' Dividend Dow Dogs are close to meeting the ideal dividend-to-price ratio, including Cisco, Chevron, and Procter & Gamble.
A court-appointed special master has found that U.S. authorities do not have evidence to support their billion-dollar fraud case accusing UnitedHealth Group of keeping overpayments from the government for patients on its Medicare insurance plans.
UnitedHealth Group Inc ticked up on Tuesday after winning a favourable finding in a long-running case against the Department of Justice over alleged Medicare fraud. A special master overseeing collection of evidence recommended rejecting the case, in which UnitedHealth is claimed to have overbilled Medicare by at least $2.1 billion.
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
NEW YORK , March 3, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices. If you currently own shares of UnitedHealth stock, please visit the firm's website at https://rosenlegal.com/submit-form/?case_id=25195 for more information.
NEW YORK, March 02, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces it is investigating potential breaches of fiduciary duties by the directors and officers of UnitedHealth Group Incorporated (NYSE: UNH) in connection with a report of an investigation by the United States Department of Justice into UnitedHealth's billing practices.
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated ("UnitedHealth" or "the Company") (NYSE:UNH) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Buying low to sell later when the stock's price is high is a time-honored investing strategy. With the benchmark S&P 500 index near its all-time high, though, now might seem like the wrong time to go looking for stocks that trade at bargain prices.